mergerWainwright Associates Limited, a leading UK-based consultancy specializing in EU regulatory affairs and pharmacovigilance, has merged with YES Pharma Services GmbH (YES), a knowledge-based service provider in the pharmaceutical, medical device and cosmetics sector.

Founded in January 1999 by Dr Chris Wainwright and Mrs Penelope Wainwright, Wainwright Associates Limited has grown organically, resulting from a mix of client referrals and repeat business. During this period we have attracted a team of 30+ high quality professionals and invested in their training, development and growth.

The decision to combine forces with YES reinforces our belief that a larger organization will allow us to offer a wider range of services in a multinational arena. YES has acquired 100% of the share capital of Wainwright Associates Limited.

Since its establishment in 1994 YES has grown steadily during the past 20 years. Today YES operates with a headcount of nearly 200 people with locations in Germany, the USA, Brazil, India and Spain. YES is an owner-managed company and one of the biggest and best known European service companies in the area of drug development, regulatory affairs and drug safety. The new cooperation with YES will provide some clear advantages for our clients and wider contacts:

  • faster international support for client products and excellent expertise locally supported by subject-specific experts
  • an even greater collective pool of experience in drug development, regulatory affairs and pharmacovigilance
  • local support with a larger team of 200 specialists working in Germany, Spain, Brazil, US and India
  • swift deployment of regional and highly qualified staff covering your short-term demand.

YES share the same values as we do and is committed to providing high quality consulting services that exceed client expectations. Together we will continue the tradition of excellent service and a high standard of expertise in an environment our clients will want to share. We will be able to provide our clients with many new services and areas of expertise in the future.

Together with YES we will offer a wider range of options in consulting, processing and support services – from drug development and registration through to product maintenance.